Holen Sie sich die Stockscreener-App
15.32
0.95%
0.09
Carlsmed Inc Aktie (CARL) Neueste Nachrichten
Carlsmed appoints Jeff Bertolini as new COO - TipRanks
Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView
Carlsmed, Inc. Announces Chief Operating Officer Appointment - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55%Tax Rate Impact - vinanet.vn
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Carlsmed (CARL) Stock Revenue Surge Meets A Wider Loss Per Share - Sahm
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com
Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionBuy Signal Reports - dars.gov.et
Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ... - Yahoo Finance UK
Carlsmed Q2 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingView
Carlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingView
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - The Manila Times
Carlsmed, Inc. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Carlsmed, Inc. $CARL Stock Holdings Lifted by Janus Henderson Group PLC - MarketBeat
Carlsmed (CARL) Earnings Date and Reports 2026 $CARL - MarketBeat
Carlsmed (CARL) Gains Favorable CMS Reimbursement Policy Boostin - GuruFocus
Carlsmed, Inc. expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures - The Manila Times
Carlsmed Inc. (CARL) Holds Near $12.59 as Support and Resistance Levels TightenSmart Money Flow Stocks - dars.gov.et
Will Carlsmed, Inc. (CARL) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
CARL|Carlsmed Ord Shs|Price:10.800|Chg%:-0.200 - TradingKey
Carlsmed Inc. (CARL) Holds Above Support as Stock Declines ModestlyStraddle Setup - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Carlsmed Inc. (CARL) Q1 2026 Earnings: EPS Beat Provides Cautious Optimism Amid Ongoing Market Volatility - vinanet.vn
KCM Capital Inc Invests $1.81 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed Inc. (CARL) Slips 1.72% as Stock Tests Support LevelsBPI Bull Confirmed - dars.gov.et
Carlsmed to report Q2FY26 results on August 5, 2026 - scanx.trade
Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 - marketscreener.com
Carlsmed to release Q2 2026 earnings on August 5 with a live webcast and call. - Pluang
Carlsmed Inc. (CARL) Slips Over 2.8% as Resistance Holds Near $11.90Dividend ETF - vinanet.vn
Carlsmed Inc. Q1 2026 Earnings: Narrower-than-Expected Loss as Pre-Revenue Medtech Advances Personalized Spine PlatformConsensus Forecast Report - vinanet.vn
Wall Street analysts think Carlsmed, Inc. (CARL) could surge 90.77%: Read this before placing a bet - MSN
Carlsmed Inc. (CARL) Q1 2026 Earnings: EPS Surpasses Estimates as Pre-Revenue Company Advances Development - dars.gov.et
Possible Turnaround For Carlsmed Insiders, Still Down US$1.7m - 富途牛牛
Gross profit of Carlsmed, Inc. – LS:A41CM7 - TradingView
Carlsmed Inc. (CARL) Slips 3.16% as Stock Trades Near Key Support LevelLiquidity Order Flow - po-news-eg.net
Carlsmed (CARL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CARL Initiates Coverage On Needham -- Rating Set to Buy - GuruFocus
Needham initiates Carlsmed stock with buy rating on implant differentiation By Investing.com - Investing.com Nigeria
Needham initiates Carlsmed stock with buy rating on implant differentiation - Investing.com
0.02%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):